June 22, 2017
PHILADELPHIA — Although some may be concerned about the use of intranasal corticosteroids for the treatment of allergic rhinitis because to their potential long-term effect on children, the scope of systemic absorption ranges from 0.3% to 30% depending on the product, according to recent presentation at the annual meeting of the American Association of Nurse Practitioners.
“Millions of children are affected by allergic rhinitis. Untreated, these children are at increased risk for sinusitis, fatigue, inattentiveness, and even dental abnormalities,” Wendy L. Wright, MS, APRN, FNP, from Wright & Associates Family Healthcare, told Infectious Diseases in Children. “It is imperative that nurse practitioners assess for this condition and treat it.”